Combined Therapy of Patients with Recurring Anogenital Herpes Infection
Abstract
Up-to-date conceptions of etiology and epidemiology of anogenital herpetic infection are described. The main mechanisms of immunological shifts in subjects with anogenital Herpes infection are discussed. The efficacy and safety of cycloferon in the combined treatment of patients with recurring anogenital herptic infection were estimated. The clinical efficacy of the combined therapy (acyclovir in a dose of 200 mg 5 times a day for 5 days + cycloferon liniment applied topically on the eruptions twice a day for 5 days) was 85% or 25% higher vs. the control.
About the Author
M. R. Rakhmatulina
Государственный научный центр дерматовенерологии и косметологии
Russian Federation
Russian Federation
References
1. Division of STD Prevention CFDCAP. Sexually transmitted disease surveillance, 1996. Atlanta: CDC 1997.
2. Cowan F.M., Johnson A.M., Ashley R. et al. Relationship between antibodies to Herpes simplex virus (HSV) and symptoms of HSV infection. J Infect Dis 1996; 174: 470.
3. Nahmias A.J., Lee F.K., Bechman-Nahmias S. Sero-epidemiological and sociological patterns of Herpes simplex virus infection in the world. Scand J Infect Dis 1990; 69: 19.
4. Буданов П.В. Проблемы терапии рецидивирующего генитального герпеса. Вопросы гинекологии, акушерства и перинатологии. 2004; 4: 3: 94-98.
Review
For citations:
Rakhmatulina M.R. Combined Therapy of Patients with Recurring Anogenital Herpes Infection. Antibiot Khimioter = Antibiotics and Chemotherapy. 2011;56(11-12):25-29. (In Russ.)
Views:
306
Email this article 